Why combine virtual care with supervised first tablet dose

Telehealth removes travel and access barriers, while an on‑label, in‑clinic first tablet dose keeps patients within FDA safety requirements for sublingual immunotherapy (SLIT) tablets. Wyndly uses both: virtual consults and ongoing at‑home care, plus an in‑person, supervised first dose when a patient starts an FDA‑approved SLIT tablet.

What “on‑label” SLIT tablet care entails (United States)

• Age eligibility: tablets are FDA‑approved across products for ages 5–65 (product‑specific: Grastek 5–65; Oralair 5–65; Ragwitek 5–65; Odactra 5–65). Always confirm the label for the specific brand your doctor prescribes.

• First dose in a healthcare setting: administer the first tablet under medical supervision with at least 30 minutes of observation to monitor for severe local or systemic reactions.

• Epinephrine auto‑injector: patients should be prescribed an auto‑injectable epinephrine and instructed/trained in its use before home dosing.

• Daily home dosing after the first dose (seasonal start varies by product; see table below).

• Key contraindications (see label): severe/unstable or uncontrolled asthma; history of severe systemic or severe local reaction to SLIT; history of eosinophilic esophagitis (EoE); hypersensitivity to excipients.

FDA‑approved SLIT tablets Wyndly prescribes

How Wyndly’s hybrid process works

1) Online consult with a board‑certified physician to review history, goals, and testing (existing results or Wyndly’s CLIA‑certified at‑home test). 2) Shared decision: SLIT tablets (single‑allergen, on‑label) vs personalized allergy drops (multi‑allergen, off‑label) based on triggers, lifestyle, and safety. 3) For tablets: Wyndly arranges a supervised first dose in a healthcare setting; you’re observed for ≥30 minutes and trained on epinephrine use. 4) Home dosing begins; you message your care team anytime and attend scheduled telehealth check‑ins. 5) For seasonal tablets (grass/ragweed), your clinician times the start before pollen season; for dust‑mite tablets, you may start any time of year. 6) Ongoing monitoring: we track efficacy, side effects, comorbid asthma control, adherence, and timing for seasonal restarts when applicable.

Safety, training, and escalation

• Training: your clinician demonstrates epinephrine use and provides written instructions; you should keep an auto‑injector accessible during home dosing.

• What’s expected: mild transient oral itching or throat irritation can occur early and usually resolves; report persistent or worsening symptoms.

• Stop and seek emergency care: throat tightness, trouble breathing/swallowing, facial/lip/tongue swelling, syncope, or generalized hives.

• Follow‑up: after any severe reaction or epinephrine use, contact your clinician to reassess eligibility and plan.

Tablets vs drops vs shots — choosing the right path

• Tablets (on‑label): strongest regulatory support for single allergens (grass, ragweed, dust mite); require supervised first dose; convenient daily home dosing.

• Drops (custom SLIT, off‑label in the U.S.): can cover multiple environmental allergens at once, fully home‑based; appropriate when multi‑allergen therapy is needed.

• Shots (SCIT): long‑standing option with robust evidence; require frequent clinic visits and post‑injection observation because of rare systemic reactions. Your Wyndly physician helps match the modality to your triggers, goals, and access constraints.

Frequently asked questions

• Do I always need an in‑person first dose? Yes—for FDA‑approved SLIT tablets, the first dose must be administered under medical supervision with ≥30 minutes of observation. Subsequent doses are taken at home.

• Why do I need an epinephrine auto‑injector? Because severe allergic reactions, while uncommon, can occur; FDA and manufacturers direct prescribers to provide and train patients on epinephrine for home use.

• Can kids use tablets? Yes—current labels allow pediatric use from age 5 for the grass, ragweed, and dust‑mite tablets (brand‑specific).

• I have asthma—am I eligible? Uncontrolled or severe asthma is a contraindication; your clinician will evaluate lung control before starting.

• How does Wyndly support hybrid care? Wyndly provides virtual consults and follow‑ups, coordinates a supervised first dose when you start a tablet, and supplies education and 24/7 messaging support.